Article info
PDFOriginal research
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction
- Correspondence to Professor Mojtaba Mojtahedzadeh, Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of); mojtahed{at}sina.tums.ac.ir
Citation
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction
Publication history
- Received July 25, 2021
- Accepted September 7, 2021
- First published September 29, 2021.
Online issue publication
March 07, 2022
Article Versions
- Previous version (7 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.